The primary risk associated with PSA testing is overdiagnosis, which can lead to overtreatment. Some prostate cancers grow so slowly that they are unlikely to cause harm during a man's lifetime. Treating these cancers can result in unnecessary side effects, including urinary incontinence and erectile dysfunction.